Arbutus Biopharma | 8-K: Current report
Arbutus Biopharma | 8-K: Current report
Arbutus Biopharma | S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plans
Arbutus Biopharma | 8-K: Current report
Arbutus Biopharma | 8-K: Arbutus Reports Second Quarter 2024 Financial Results and Provides Corporate Update
Arbutus Biopharma | 8-K: Current report
Arbutus Biopharma | 8-K: Current report
Arbutus Biopharma | 8-K: Current report
Arbutus Biopharma | 8-K: Current report
Arbutus Biopharma | 8-K: Arbutus Reports First Quarter 2024 Financial Results and Provides Corporate Update
Arbutus Biopharma | 8-K: Current report
Arbutus Biopharma | DEF 14A: Definitive information statements
Arbutus Biopharma | DEFA14A: Others
Arbutus Biopharma | 8-K: Current report
Arbutus Biopharma | 8-K: Arbutus Reports Fourth Quarter and Year End 2023 Financial Results and Provides Corporate Update
Arbutus Biopharma | 8-K: Current report
Arbutus Biopharma | 8-K: Current report
Arbutus Biopharma | 8-K: Current report
Arbutus Biopharma | 8-K: Arbutus Reports Third Quarter 2023 Financial Results and Provides Corporate Update
Arbutus Biopharma | 8-K: Current report
No Data
No Data